Tyers Asset Management’s Twist Bioscience TWST Stock Holding History

Tyers Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$352K	Buy	14,752 +14,080	+2,095%	+$409K	0.01%	568
2019 Q2	$19K	Buy	672 +336	+100%	+$8.89K	﹤0.01%	963
2019 Q1	$8K	Sell	336 -256	-43%	-$5.78K	﹤0.01%	975
2018 Q4	$14K	Buy	+592	New	+$13.1K	﹤0.01%	927

Other funds holding TWST

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Tyers Asset Management's TWST Position: Q3 2019 in Review

Tyers Asset Management increased its Twist Bioscience (TWST) stake by 2,095% in Q3 2019, buying an estimated $409K and bringing the position to 14,752 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #568.

Tyers Asset Management first reported a position in TWST in Q4 2018 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold TWST as of Q3 2019.

Tyers Asset Management held 14,752 shares of Twist Bioscience worth $352K as of Q3 2019.
Tyers Asset Management bought 14,080 Twist Bioscience shares in Q3 2019, an estimated $409K.
Twist Bioscience made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #568 holding.
Tyers Asset Management first reported a position in Twist Bioscience in Q4 2018 and has held it in 4 quarters since.
84 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.